ConductScience.org, home

Trial · NCT07880171

Intensive Home-based Transcranial Direct Current Stimulation for Long COVID

NCT07880171, Not applicable, Completed, Hospital de Basurto

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Intensive Home-based Transcranial Direct Current Stimulation for Long COVID. Trials, record NCT07880171. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07880171

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Intensive Home-based Transcranial Direct Current Stimulation for Long COVID
NCT number
NCT07880171
Status
Completed
Phases
Not applicable
Enrollment
40 participants, actual
Lead sponsor
Hospital de Basurto
Conditions
Long COVID Fatigue, Brain Fog, Chronic Pain, Depression Anxiety Disorder
Interventions
Transcranial Direct Current Stimulation
First posted
2026-10-19
Last updated
2026-10-19

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in fatigue severity measured by the Fatigue Assessment Scale (FAS)From enrollment to the end of treatment at 14 weeksTotal score ranges from 10 to 50, with higher scores indicating greater fatigue severity.
SecondaryChange in depressive symptoms measured by the Hospital Anxiety and Depression Scale (HADS-D)From enrollment to the end of treatment at 14 weeksSubscale score ranges from 0 to 21, with higher scores indicating greater symptom severity
SecondaryChange in self-reported pain intensity measured by the Visual Analogue Scale (VAS)From enrollment to the end of treatment at 14 weeksScore ranges from 0 (no pain) to 10 (worst possible pain).
SecondaryChange in cognitive function measured by the Montreal Cognitive Assessment (MoCA)From enrollment to the end of treatment at 14 weeksCognition evaluation, using Montreal Cognitive Assessment \[MoCA\] test
SecondaryChange in health-related quality of life measured by the PROMIS Global Health 10 questionnaireFrom enrollment to the end of treatment at 14 weeksChange in health-related quality of life measured by the PROMIS Global Health 10 questionnaire

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07880171

GET https://conductscience.org/api/trials/v1/NCT07880171/registered